Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
After finishing at $0.67 in the prior trading day, Agilon Health Inc (NYSE: AGL) closed at $0.7, up 3.94%. In other words, the price has increased by $3.94 from its previous closing price. On the day, 7.19 million shares were traded. AGL stock price reached its highest trading level at $0.7328 during the session, while it also had its lowest trading level at $0.6723.
Ratios:
Our goal is to gain a better understanding of AGL by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.08 and its Current Ratio is at 1.08. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.01.
On August 06, 2025, Citigroup Downgraded its rating to Neutral which previously was Buy but kept the price unchanged to $1.
Citigroup Upgraded its Neutral to Buy on April 25, 2025, while the target price for the stock was maintained at $5.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AGL now has a Market Capitalization of 289709632 and an Enterprise Value of 15976625. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.05 while its Price-to-Book (P/B) ratio in mrq is 0.95. Its current Enterprise Value per Revenue stands at 0.003 whereas that against EBITDA is -0.047.
Stock Price History:
The Beta on a monthly basis for AGL is 0.05, which has changed by -0.6588832 over the last 52 weeks, in comparison to a change of 0.13329959 over the same period for the S&P500. Over the past 52 weeks, AGL has reached a high of $6.08, while it has fallen to a 52-week low of $0.51. The 50-Day Moving Average of the stock is -6.70%, while the 200-Day Moving Average is calculated to be -66.28%.
Shares Statistics:
The stock has traded on average 9.20M shares per day over the past 3-months and 7750540 shares per day over the last 10 days, according to various share statistics. A total of 414.57M shares are outstanding, with a floating share count of 304.83M. Insiders hold about 26.47% of the company’s shares, while institutions hold 68.69% stake in the company. Shares short for AGL as of 1764288000 were 17931905 with a Short Ratio of 1.95, compared to 1761868800 on 20881325. Therefore, it implies a Short% of Shares Outstanding of 17931905 and a Short% of Float of 7.0700005.
Earnings Estimates
The market rating for Agilon Health Inc (AGL) is a result of the insights provided by 8.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.04, with high estimates of $0.02 and low estimates of -$0.1.
Analysts are recommending an EPS of between -$0.59 and -$0.85 for the fiscal current year, implying an average EPS of -$0.74. EPS for the following year is -$0.42, with 12.0 analysts recommending between -$0.33 and -$0.52.
Revenue Estimates
14 analysts predict $1.46B in revenue for. The current quarter. It ranges from a high estimate of $1.54B to a low estimate of $1.42B. As of. The current estimate, Agilon Health Inc’s year-ago sales were $1.52BFor the next quarter, 14 analysts are estimating revenue of $1.59B. There is a high estimate of $1.67B for the next quarter, whereas the lowest estimate is $1.5B.
A total of 16 analysts have provided revenue estimates for AGL’s current fiscal year. The highest revenue estimate was $5.9B, while the lowest revenue estimate was $5.78B, resulting in an average revenue estimate of $5.82B. In the same quarter a year ago, actual revenue was $6.06BBased on 16 analysts’ estimates, the company’s revenue will be $6.01B in the next fiscal year. The high estimate is $6.41B and the low estimate is $5.51B.
